Related Experiment Video
Updated: Oct 18, 2025

Unbiased Deep Sequencing of RNA Viruses from Clinical Samples
Published on: July 2, 2016
Sequencing the Complete Genome of COVID-19 Virus from Clinical Samples Using the Sanger Method
Roujian Lu1, Peihua Niu1, Li Zhao1
1Key Laboratory of Biosafety, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China.
Insights
Sanger sequencing provides a cost-effective method for obtaining complete severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes from clinical samples. This technique enables the monitoring of viral genetic variations in COVID-19 infections without expensive equipment.
Area of Science:
- Virology
- Genomics
- Molecular Biology
Background:
- Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
- Complete SARS-CoV-2 genomes have been previously sequenced using next-generation sequencing (NGS).
Purpose of the Study:
- To provide technical data for sequencing complete SARS-CoV-2 genomes from clinical samples using the Sanger sequencing method.
- To demonstrate the feasibility of using Sanger sequencing for viral genome analysis.
Main Methods:
- Sanger sequencing was employed to obtain complete genomes of SARS-CoV-2 from clinical samples.
- Two complete SARS-CoV-2 genomes (WH19004-S and GX0002) were successfully sequenced.
- Single nucleotide polymorphisms (SNPs) were identified in specific regions of the WH19004-S genome.
Main Results:
- Complete genome sequences of SARS-CoV-2 were obtained using the Sanger method.
- Two specific single nucleotide polymorphisms (SNPs) were identified in the ORF7a and ORF8 regions of the WH19004-S genome.
- The obtained sequences were of high quality.
Conclusions:
- Sanger sequencing is a viable and cost-effective alternative to NGS for complete SARS-CoV-2 genome sequencing.
- This method can generate high-quality data for monitoring viral genetic variations in COVID-19.
- It supports public health surveillance of SARS-CoV-2 without the need for expensive equipment.
Abstract:
What is already known on this topic?
Abstract:
Coronavirus disease 2019 (COVID-19), a disease caused by a novel human coronavirus named the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 virus, was reported in December 2019. Complete genomes of the COVID-19 virus from clinical samples using next generation sequencing (NGS) have been reported.
Abstract:
What is added by this report?
Abstract:
Here we provide the technical data for sequencing complete genome of COVID-19 virus from clinical samples using the Sanger method. Two complete COVID-19 virus genome sequences (named WH19004-S and GX0002) were obtained from clinical samples of COVID-19 patients, and two single nucleotide polymorphisms (SNPs) in ORF7a (T/C, nt 27,493) and ORF8 (T/C, nt 28,253) of WH19004-S were identified by Sanger sequencing.
Abstract:
What are the implications for public health practice?
Abstract:
The COVID-19 virus genome sequencing by Sanger method reported here could be used to generate data of high enough quality without requirement for expensive NGS equipment, which support sequencing complete genomes from clinical samples and monitoring of viral genetic variations of COVID-19 infections.
More Related Videos
Related Concept Videos
Sanger Sequencing
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

